Press release
Orphan Drugs - Top Companies Regional and Data Analysis to (2021-2031)
Orphan Drugs Market
Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00005799/?utm_source=OpenPR&utm_medium=10129
Major Companies operating in the Orphan Drugs Market are:
• F. Hoffmann-La Roche Ltd
• Eli Lilly and Company
• Alexion
• CELGENE CORPORATION
• Novartis AG
• Takeda Pharmaceuticals Company Limited
• Biogen
• Bristol-Myers Squibb Company
• Bayer AG
• Sanofi
Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Ankit Mathur
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Orphan Drugs - Top Companies Regional and Data Analysis to (2021-2031) here
News-ID: 3881193 • Views: …
More Releases from The Insight Partners
Memory Implants Market Projected to Grow Significantly, Fueled by AI and Neurosc …
New York, US - September 3, 2025 - A new report from The Insight Partners, titled "Memory Implants Market - Global Analysis and Forecast," projects that the global market for memory implants is poised for substantial growth. The report indicates that this market expansion is being propelled by increasing investment in neurodegenerative disease research, a surge in demand for brain-computer interface technologies, and the rising adoption of personalized medicine.
Get Sample…
How Smart Tech and Automation are Powering the Motor Protection Market
New York, US - September 03, 2025- Based on a recent report by The Insight Partners, the global market for motor protection is on a path of significant growth, with projections extending to 2031. The report, titled "Motor Protection Market Share, Size, Trends, and Forecast by 2031," highlights that this expansion is primarily driven by widespread
industrialization, advancements in technology, and the implementation of more stringent safety regulations across the…
Medical Cooling System Market Poised for Substantial Growth, Driven by Patient S …
New York, US - September 04, 2025- According to a new report from The Insight Partners, titled "Medical Cooling System Market - Global Analysis and Forecast," the global market for medical cooling systems is on a path of substantial growth. The report projects that the market is being propelled by the critical need for patient safety, an expanding number of medical procedures, and ongoing technological evolution in diagnostic and therapeutic…
Report Forecasts Significant Expansion for Massage Tables Market Due to Wellness …
New York, US - September 04, 2025- The Insight Partners' new report, "Massage Tables Market - Global Analysis and Forecast," projects a strong expansion for the global massage tables market. The report finds that market growth is being fueled by an increasing need for professional massage services, a heightened public awareness of health benefits, and continuous technological innovation in table design.
Download PDF Sample Copy @ https://www.theinsightpartners.com/sample/TIPRE00026956/?utm_source=OpenPR&utm_medium=10813
Key Market Drivers: Wellness, Health,…
More Releases for Orphan
Acquired Orphan Blood Disease Market
Acquired Orphan Blood Disease Market to reach over USD 18.93 billion by the year 2031 - Exclusive Report by InsightAce Analytic
According to a new report by InsightAce Analytic, the "Acquired Orphan Blood Disease Market" in terms of revenue was estimated to be worth $8.65 billion in 2023 and is poised to reach $18.93 billion by 2031, growing at a CAGR of 10.47% from 2024 to 2031.
Get Free Access to…
Orphan Drugs Market Size to Hit $3199.3 Billion by 2028 | Orphan Drugs Industry …
Market Overview:
According to our experience research team, Orphan Drugs Market was valued at USD 112.36 Billion in 2021, and the global Orphan Drugs industry is projected to reach a value of USD 3199.3 Billion by 2028, at a CAGR of 7.4% during the forecast period 2022-2028
Vantage Market Research is a collection of market research studies on several industries, such as Chemicals, semiconductors & Electronics, Food & Beverages Technology, Energy &…
Orphan Drugs for Cancer Pipeline Analysis
A huge market opportunity is offered by small patient population which suffers from rare or orphan diseases. Among the category of new orphan drugs, Oncology account for the largest disease group in recent years. It has been observed that majority of the orphan drugs in the clinical stages are for rare cancer disease drugs, and are in the late stages of the pipeline. Some of the drugs are being developed…
US Orphan Drug Pipeline Analysis
In recent years, the pharmaceutical industry has been experiencing a paradigm shift. While a large pool of patients was considered as a major source of revenue for pharma companies in the past, the focus is now gradually shifting to small sections of patients suffering from rare disease. In US, this pool of patients is gradually growing and orphan drugs are becoming an extremely attractive business proposition for the pharmaceuticals industry.…
Europe Orphan Drugs Pipeline Analysis
“Europe Orphan Drugs Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drug profiles under Orphan Drugs status in Europe. Research report covers all the ongoing drug development in various phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Chemical Formula, Country of Development and detailed analysis on the development process. The information for particular drug…
Global Orphan Drug Pipeline Analysis
In recent years, the pharmaceutical industry has been experiencing a paradigm shift. While a large pool of patients was considered as a major source of revenue for pharma companies in the past, the focus is now gradually shifting to small sections of patients suffering from rare disease. In US & Europe, this pool of patients is gradually growing and orphan drugs are becoming an extremely attractive business proposition for the…
